3D Bioprinting Market Analysis on Segments, Size, Share, Trends, COVID-19 Impact, Competitive Analysis, Growth Opportunities and Key Insights to 2027

1 Executive Summary

3D Bioprinting Market from Consainsights analyses the 3D Bioprinting Market Market in the Life Sciences industry over the forecast period to 2027.

Figure 1: 3D Bioprinting Market Size, 2019-2027

3D Bioprinting Market research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

3D Bioprinting Market segmentation includes Component, Material, Application, End User, Region and Geography.

All segmentations encompasses the key innovations and micro & macro trends, companies/manufacturers operating in this space along with their usage and penetration with respect to the wide range of End Users. Additionally, market sizing information along with the key factors such as market drivers, restraints, opportunities and challenges which are likely to be influencing the market growth are outlined in this report.

Based on the Component, the 3D Bioprinting Market analysis covers Bioprinters, Bioinks.

Figure 2: 3D Bioprinting Market Share (%), Component 2021

Based on the Material, the 3D Bioprinting Market analysis covers Living Cells, Hydrogels, Extracellular Matrices, Other Biomaterials.

Figure 3: 3D Bioprinting Market Share (%), Material 2021

Based on the Application, the 3D Bioprinting Market analysis covers Research Applications, Clinical Applications.

Figure 4: 3D Bioprinting Market Share (%), Application 2021

Based on the End User, the 3D Bioprinting Market analysis covers Research Organizations & Academic Institutes, Biopharmaceutical Companies, Hospitals.

Figure 5: 3D Bioprinting Market Share (%), End User 2021

Based on the Region, the 3D Bioprinting Market analysis covers North America, Europe, Asia Pacific, Rest of the World.

Figure 6: 3D Bioprinting Market Share (%), Region 2021

Key companies operating in the market include Advanced Solutions Life Sciences, Allevi Inc., Aspect Biosystems Ltd., Cellink, Cyfuse Biomedical K.K., Digilab, Inc., Envisiontec, Gesim, Nano3D Biosciences, Inc., Organovo Holdings, Inc., Poietis, Regenhu, Regenovo Biotechnology Co., Ltd., Rokit Healthcare, Tevido Biodevices and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Moreover, the competitive analysis includes the companies deals such as Mergers, Acquisitions, Partnerships and so on along with the expansion areas focusing on the additional geographies, future insights for success and market share analysis. Major players strategies include the launch of the innovative product lines along with the emphasis on the partnerships and acquisitions to standardize their market share in the market space.

Market Research methodology includes the triangulation of the data from the data sources such as Primary Market Research approach and Secondary Market Research Approach along with the data from the trade bodies and industry standard publications and data sources. Primary inputs from the industry experts and the market respondents from the respective industries to obtain very critical information to assess the future growth prospects of the market. The final data is triangulated and thoroughly validated considering all the data sources using the bottom-up and the top-down approaches to estimate the market sizing of the individual segments.

2 Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.
The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.
The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.
Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.
Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.
As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

3 By Component

Introduction

By By Component, The 3D Bioprinting Market analysis covers Bioprinters, Bioinks.

Table: 1: 3D Bioprinting Market Size, By By Component

Bioprinters

The Bioprinters segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Bioinks

The Bioinks segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

4 By Material

Introduction

By By Material, The 3D Bioprinting Market analysis covers Living Cells, Hydrogels, Extracellular Matrices, Other Biomaterials.

Table: 2: 3D Bioprinting Market Size, By By Material

Living Cells

The Living Cells segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Hydrogels

The Hydrogels segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Extracellular Matrices

The Extracellular Matrices segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Other Biomaterials

The Other Biomaterials segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

5 By Application

Introduction

By By Application, The 3D Bioprinting Market analysis covers Research Applications, Clinical Applications.

Table: 3: 3D Bioprinting Market Size, By By Application

Research Applications

The Research Applications segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Clinical Applications

The Clinical Applications segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

6 By End User

Introduction

By By End User, The 3D Bioprinting Market analysis covers Research Organizations & Academic Institutes, Biopharmaceutical Companies, Hospitals.

Table: 4: 3D Bioprinting Market Size, By By End User

Research Organizations & Academic Institutes

The Research Organizations & Academic Institutes segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Biopharmaceutical Companies

The Biopharmaceutical Companies segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Hospitals

The Hospitals segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

7 By Region

Introduction

By By Region, The 3D Bioprinting Market analysis covers North America, Europe, Asia Pacific, Rest of the World.

Table: 5: 3D Bioprinting Market Size, By By Region

North America

The North America segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Europe

The Europe segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Asia Pacific

The Asia Pacific segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Rest of the World

The Rest of the World segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

8 North America

Introduction

Based on the North America, the 3D Bioprinting Market analysis covers US, Canada.

Table 6: North America 3D Bioprinting Market Size, Component 2019-2027

Table 7: North America 3D Bioprinting Market Size, Material 2019-2027

Table 8: North America 3D Bioprinting Market Size, Application 2019-2027

Table 9: North America 3D Bioprinting Market Size, End User 2019-2027

Table 10: North America 3D Bioprinting Market Size, Region 2019-2027

US

Table 11: US 3D Bioprinting Market Size, Component 2019-2027

Table 12: US 3D Bioprinting Market Size, Material 2019-2027

Table 13: US 3D Bioprinting Market Size, Application 2019-2027

Table 14: US 3D Bioprinting Market Size, End User 2019-2027

Table 15: US 3D Bioprinting Market Size, Region 2019-2027

Canada

Table 18: Canada 3D Bioprinting Market Size, Application 2019-2027

Table 19: Canada 3D Bioprinting Market Size, End User 2019-2027

Table 20: Canada 3D Bioprinting Market Size, Region 2019-2027

9 Europe

Introduction

Based on the Europe, the 3D Bioprinting Market analysis covers Germany, United Kingdom, France, Spain, Russia, Italy, Rest of Europe.

Table 21: Europe 3D Bioprinting Market Size, Component 2019-2027

Table 22: Europe 3D Bioprinting Market Size, Material 2019-2027

Table 23: Europe 3D Bioprinting Market Size, Application 2019-2027

Table 24: Europe 3D Bioprinting Market Size, End User 2019-2027

Table 25: Europe 3D Bioprinting Market Size, Region 2019-2027

Germany

Table 28: Germany 3D Bioprinting Market Size, Application 2019-2027

Table 29: Germany 3D Bioprinting Market Size, End User 2019-2027

Table 30: Germany 3D Bioprinting Market Size, Region 2019-2027

United Kingdom

Table 33: United Kingdom 3D Bioprinting Market Size, Application 2019-2027

Table 34: United Kingdom 3D Bioprinting Market Size, End User 2019-2027

Table 35: United Kingdom 3D Bioprinting Market Size, Region 2019-2027

France

Table 38: France 3D Bioprinting Market Size, Application 2019-2027

Table 39: France 3D Bioprinting Market Size, End User 2019-2027

Table 40: France 3D Bioprinting Market Size, Region 2019-2027

Spain

Table 43: Spain 3D Bioprinting Market Size, Application 2019-2027

Table 44: Spain 3D Bioprinting Market Size, End User 2019-2027

Table 45: Spain 3D Bioprinting Market Size, Region 2019-2027

Russia

Table 48: Russia 3D Bioprinting Market Size, Application 2019-2027

Table 49: Russia 3D Bioprinting Market Size, End User 2019-2027

Table 50: Russia 3D Bioprinting Market Size, Region 2019-2027

Italy

Table 53: Italy 3D Bioprinting Market Size, Application 2019-2027

Table 54: Italy 3D Bioprinting Market Size, End User 2019-2027

Table 55: Italy 3D Bioprinting Market Size, Region 2019-2027

Rest of Europe

Table 58: Rest of Europe 3D Bioprinting Market Size, Application 2019-2027

Table 59: Rest of Europe 3D Bioprinting Market Size, End User 2019-2027

Table 60: Rest of Europe 3D Bioprinting Market Size, Region 2019-2027

10 Asia-Pacific

Introduction

Based on the Asia-Pacific, the 3D Bioprinting Market analysis covers China, Japan, India, Southeast Asia, Australia & New Zealand, Rest of Asia-Pacific.

Table 61: Asia-Pacific 3D Bioprinting Market Size, Component 2019-2027

Table 62: Asia-Pacific 3D Bioprinting Market Size, Material 2019-2027

Table 63: Asia-Pacific 3D Bioprinting Market Size, Application 2019-2027

Table 64: Asia-Pacific 3D Bioprinting Market Size, End User 2019-2027

Table 65: Asia-Pacific 3D Bioprinting Market Size, Region 2019-2027

China

Table 68: China 3D Bioprinting Market Size, Application 2019-2027

Table 69: China 3D Bioprinting Market Size, End User 2019-2027

Table 70: China 3D Bioprinting Market Size, Region 2019-2027

Japan

Table 73: Japan 3D Bioprinting Market Size, Application 2019-2027

Table 74: Japan 3D Bioprinting Market Size, End User 2019-2027

Table 75: Japan 3D Bioprinting Market Size, Region 2019-2027

India

Table 78: India 3D Bioprinting Market Size, Application 2019-2027

Table 79: India 3D Bioprinting Market Size, End User 2019-2027

Table 80: India 3D Bioprinting Market Size, Region 2019-2027

Southeast Asia

Table 83: Southeast Asia 3D Bioprinting Market Size, Application 2019-2027

Table 84: Southeast Asia 3D Bioprinting Market Size, End User 2019-2027

Table 85: Southeast Asia 3D Bioprinting Market Size, Region 2019-2027

Australia & New Zealand

Table 88: Australia & New Zealand 3D Bioprinting Market Size, Application 2019-2027

Table 89: Australia & New Zealand 3D Bioprinting Market Size, End User 2019-2027

Table 90: Australia & New Zealand 3D Bioprinting Market Size, Region 2019-2027

Rest of Asia-Pacific

Table 93: Rest of Asia-Pacific 3D Bioprinting Market Size, Application 2019-2027

Table 94: Rest of Asia-Pacific 3D Bioprinting Market Size, End User 2019-2027

Table 95: Rest of Asia-Pacific 3D Bioprinting Market Size, Region 2019-2027

11 Middle-East & Africa

Introduction

Based on the Middle-East & Africa, the 3D Bioprinting Market analysis covers Middle East, Africa, Rest of Middle East & Africa.

Table 96: Middle-East & Africa 3D Bioprinting Market Size, Component 2019-2027

Table 97: Middle-East & Africa 3D Bioprinting Market Size, Material 2019-2027

Table 98: Middle-East & Africa 3D Bioprinting Market Size, Application 2019-2027

Middle East

Table 103: Middle East 3D Bioprinting Market Size, Application 2019-2027

Table 104: Middle East 3D Bioprinting Market Size, End User 2019-2027

Table 105: Middle East 3D Bioprinting Market Size, Region 2019-2027

Africa

Table 108: Africa 3D Bioprinting Market Size, Application 2019-2027

Table 109: Africa 3D Bioprinting Market Size, End User 2019-2027

Table 110: Africa 3D Bioprinting Market Size, Region 2019-2027

Rest of Middle East & Africa

Table 113: Rest of Middle East & Africa 3D Bioprinting Market Size, Application 2019-2027

Table 114: Rest of Middle East & Africa 3D Bioprinting Market Size, End User 2019-2027

Table 115: Rest of Middle East & Africa 3D Bioprinting Market Size, Region 2019-2027

12 Latin America

Introduction

Based on the Latin America, the 3D Bioprinting Market analysis covers Brazil, Argentina, Mexico, Colombia, Rest of Latin America.

Table 116: Latin America 3D Bioprinting Market Size, Component 2019-2027

Table 117: Latin America 3D Bioprinting Market Size, Material 2019-2027

Table 118: Latin America 3D Bioprinting Market Size, Application 2019-2027

Table 119: Latin America 3D Bioprinting Market Size, End User 2019-2027

Table 120: Latin America 3D Bioprinting Market Size, Region 2019-2027

Brazil

Table 123: Brazil 3D Bioprinting Market Size, Application 2019-2027

Table 124: Brazil 3D Bioprinting Market Size, End User 2019-2027

Table 125: Brazil 3D Bioprinting Market Size, Region 2019-2027

Argentina

Table 128: Argentina 3D Bioprinting Market Size, Application 2019-2027

Table 129: Argentina 3D Bioprinting Market Size, End User 2019-2027

Table 130: Argentina 3D Bioprinting Market Size, Region 2019-2027

Mexico

Table 133: Mexico 3D Bioprinting Market Size, Application 2019-2027

Table 134: Mexico 3D Bioprinting Market Size, End User 2019-2027

Table 135: Mexico 3D Bioprinting Market Size, Region 2019-2027

Colombia

Table 138: Colombia 3D Bioprinting Market Size, Application 2019-2027

Table 139: Colombia 3D Bioprinting Market Size, End User 2019-2027

Table 140: Colombia 3D Bioprinting Market Size, Region 2019-2027

Rest of Latin America

Table 143: Rest of Latin America 3D Bioprinting Market Size, Application 2019-2027

Table 144: Rest of Latin America 3D Bioprinting Market Size, End User 2019-2027

Table 145: Rest of Latin America 3D Bioprinting Market Size, Region 2019-2027

13 Company Analysis

Introduction

Key companies operating in the market include Advanced Solutions Life Sciences, Allevi Inc., Aspect Biosystems Ltd., Cellink, Cyfuse Biomedical K.K., Digilab, Inc., Envisiontec, Gesim, Nano3D Biosciences, Inc., Organovo Holdings, Inc., Poietis, Regenhu, Regenovo Biotechnology Co., Ltd., Rokit Healthcare, Tevido Biodevices and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.